# Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)

Study · id `cardio:ct-nct07389460` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07389460](<https://clinicaltrials.gov/study/NCT07389460>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07389460

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 820 participants.

## Technical summary

Registry record NCT07389460. Randomized; quadruple masking; primary purpose treatment. Start 2026-04-07 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 820 participants (planned count; ClinicalTrials.gov record NCT07389460, source copy `cardio:ctgov-nct07389460-2026-09-09`, retrieved 2026-10-26)
- Started: 2026-04-07 (actual) (ClinicalTrials.gov record NCT07389460, source copy `cardio:ctgov-nct07389460-2026-09-09`, retrieved 2026-10-26)
- Primary completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07389460, source copy `cardio:ctgov-nct07389460-2026-09-09`, retrieved 2026-10-26)
- Completion: 2028-03-31 (anticipated) (ClinicalTrials.gov record NCT07389460, source copy `cardio:ctgov-nct07389460-2026-09-09`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07389460, source copy `cardio:ctgov-nct07389460-2026-09-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07389460-2026-09-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Intravenous rhPro-UK
- Intervention (Drug): Intravenous placebo
- Intervention (Procedure): Endovascular thrombectomy
- Lead sponsor: First Affiliated Hospital Xi'an Jiaotong University
- Lead sponsor class: OTHER
- Collaborator: Tasly Pharmaceutical Group Co., Ltd
- Collaborator class: INDUSTRY
- Collaborator: Peking Union Medical College Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: First Affiliated Hospital Xi'an Jiaotong University (`cardio:org-first-affiliated-hospital-xi-an-jiaotong-university`)
- Registry lists this organization as a collaborator: Tasly Pharmaceutical Group Co., Ltd (`cardio:org-tasly-pharmaceutical-group-co-ltd`)
- Registry lists this organization as a collaborator: Peking Union Medical College Hospital (`cardio:org-peking-union-medical-college-hospital`)

## Provenance

Content hash: bb3c9cfbb838942bfba58eafe9716a81a0d748ec16b1dd1c7b69b65d008d126f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
